Skip to main content
Skip to navigation

All Clinical trial authorisation (CTA) application articles

Journal
Evolution of GMO requirements for innovative investigational medicinal products upon transition to the EU CTR

2023-05-18T12:58:00Z

The EU CTR replaced the EU CTD on 31 January 2022, which impacts investigational medicinal products that fall under genetically modified organisms (GMO-IMPs).